The design and synthesis of novel and hydrolytically stable structural analogues of MenA CPS may provide additional tools for the development of therapies against this disease. In this context, the structural features of the natural phosphorylated monomer have been analyzed and compared to those of its carbs analogueMINECO for Grant CTQ2015-64597-C2-1P and for the Severo Ochoa Excellence Accreditation (SEV-2016-0644). We also thank MINECO (projects CTQ2015-67727-R to F. C., CTQ2015-70524-R and RYC- 2013-14706 to G. J. O.)
In order to find suitable stable vaccine candidates against Neisseria meningitidis group A, several ...
The capsular polysaccharide antigen of Neisseria meningitidis group I was isolated by Cetavlon preci...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in Africa. The...
Neisseria meningitidis serogroup A (MenA) is an aerobic diplococcal Gram-negative bacterium responsi...
The resistance to Neisseria meningitidis (N. m.), a gram-negative bacterium causing meningitis, is m...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Neisseria meningitidis is a Gram-negative encapsulated bacterium that is a major cause of meningitis...
<i>Neisseria meningitidis</i> type A (MenA) is a Gram-negative encapsulated bacterium that is a majo...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that is a major cause...
The development of a glycoconjugate vaccine against N. meningitidis type A bacterium is greatly hamp...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that causes recurrent...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that may cause expl...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
This thesis describes the synthesis of structures related to the capsular polysaccharide of Neisseri...
The conformational behavior of methyl (2-acetamido-2-deoxy-a-D-mannopyranosyl)phosphate 1, and its ...
In order to find suitable stable vaccine candidates against Neisseria meningitidis group A, several ...
The capsular polysaccharide antigen of Neisseria meningitidis group I was isolated by Cetavlon preci...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in Africa. The...
Neisseria meningitidis serogroup A (MenA) is an aerobic diplococcal Gram-negative bacterium responsi...
The resistance to Neisseria meningitidis (N. m.), a gram-negative bacterium causing meningitis, is m...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Neisseria meningitidis is a Gram-negative encapsulated bacterium that is a major cause of meningitis...
<i>Neisseria meningitidis</i> type A (MenA) is a Gram-negative encapsulated bacterium that is a majo...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that is a major cause...
The development of a glycoconjugate vaccine against N. meningitidis type A bacterium is greatly hamp...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that causes recurrent...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that may cause expl...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
This thesis describes the synthesis of structures related to the capsular polysaccharide of Neisseri...
The conformational behavior of methyl (2-acetamido-2-deoxy-a-D-mannopyranosyl)phosphate 1, and its ...
In order to find suitable stable vaccine candidates against Neisseria meningitidis group A, several ...
The capsular polysaccharide antigen of Neisseria meningitidis group I was isolated by Cetavlon preci...
Neisseria meningitidis is a major cause of bacterial meningitis worldwide, especially in Africa. The...